#inflammation — Saturday, May 23, 2026 (2 items)
| 0 | 💬 0 |
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.
(linkinghub.elsevier.com)
|
The Lancet 2026-05-23 | #antibody #inflammation #immunotherapy #copd #exacerbation | |
| 0 | 💬 0 |
Ulcerative colitis-driven gut dysbiosis exacerbates periodontal bone loss through the gut-oral axis /Th17/Treg imbalance.
(nature.com)
|
npj Biofilms and Microbiomes 2026-05-23 | #microbiome #metagenomics #dysbiosis #inflammation #colitis |